![]() | The topic of this article may not meet Wikipedia's notability guideline for biographies .(October 2022) |
Severin Schwan | |
---|---|
![]() Schwan in 2012 | |
Born | Severin Anton Schwan November 17, 1967 Hall in Tirol, Austria |
Citizenship |
|
Education | Akademisches Gymnasium Innsbruck |
Alma mater | University of Innsbruck University of York University of Oxford |
Title | Chairman of the Board of Roche Holding AG |
Spouse | Ingeborg Stix (m. 1995) |
Children | 3 |
Severin Anton Schwan (born November 17, 1967) is an Austrian business executive. He is the current chairman of the board and former CEO (2008–2023) of the Roche Group.
Schwan joined the Roche Group in 1993 as a trainee and has stayed with the company ever since. [1] [2]
Severin Schwan graduated from the Akademisches Gymnasium Innsbruck and then studied economics at the University of Innsbruck, University of York, and University of Oxford as well as law at the University of Innsbruck. [3] He completed both subjects in 1991 with a master's degree and acquired the title Mag. iur. and Mag. rer. soc. oec. He then obtained his Doctorate in Law in 1993. [4]
Schwan started his career as a trainee at the Roche office in Basel, Switzerland. He has worked in a number of positions across the globe for Roche. He was appointed CEO of the Roche Group at its Annual General Meeting on March 4, 2008, replacing Franz B. Humor. [5] Previously, Schwan was managing director of Roche's Diagnostics Division.
He has been a member of the Board of Directors of Roche Holding AG since 2013. At the Annual General Meeting on March 14, 2023, he was elected chairman of the Board of Directors, succeeding Christoph Franz. [6] Thomas Schinecker became Schwan's successor as CEO. [7]
From 2014 to 2022, he was a member of the board of directors of Credit Suisse, and from 2017 its vice chairman. He stepped down from the position of vice-chair in March 2022. [8] [9]
He was on the board at Chugai Pharmaceutical Co., Ltd. Schwan has been a member of the International Business Leaders Advisory Council for the Mayor of Shanghai (IBLAC) since 2009 and Vice President since 2022. [10]
From 2016 to 2020, he was Vice President of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). [11]
Born to an Austrian-German family, Schwan is citizen of both countries. He was also granted Swiss citizenship in 2020. [12] [13] Schwan is married, has three children and lives in the Basel suburb of Riehen. [14] [15]
Arthur D. Levinson is an American businessman who is the chairman of Apple Inc. (2011–present) and chief executive officer (CEO) of Calico. He is the former CEO (1995–2009) and chairman (1999–2014) of Genentech.
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is a trade association that represents internationally over 90 pharmaceutical companies and associations around the world. IFPMA is based in Geneva and is in official relations with the United Nations where it contributes industry expertise to global health discussions.
Raymond V. Gilmartin is an American former business executive and an adjunct professor of management practice at the Harvard Business School.
Fred Hassan, is a Pakistan-born American business executive who works for the private equity giant Warburg Pincus and previously was CEO of three global pharmaceutical companies.
Mutual of America Life Insurance Company is an American provider of retirement services and investments to employers, employees and individuals. Founded in 1945, the company provides products and services to help its customers build and preserve assets.
Christoph Franz is a German engineer and manager who served as chief executive officer of Lufthansa from 2011 until 2014.
Gregory David Wasson is an American businessman. He is the co-founder and president of Wasson Enterprise, a family-based investment office, the executive chairman of Innventure, co-founder of CoolerScreens, and the former president and chief executive officer (CEO) of Walgreens Boots Alliance (NASDAQ:WBA).
Ulrich Körner is a German-Swiss businessman. In March 2021, he was named CEO Asset Management of Credit Suisse until July 2022, when he was appointed CEO of Credit Suisse AG.
Ajaypal Singh "Ajay" Banga is an Indian-born American business executive. He is currently the president of the World Bank Group. He was the executive chairman of Mastercard, after having previously served as president and chief executive officer (CEO) of the company from July 2010 until December 31, 2020. He retired from this position on December 31, 2021, and joined General Atlantic as its vice chairman.
Alex Gorsky is an American businessman. He is the former chairman and CEO of Johnson & Johnson. Gorsky stepped down as CEO of Johnson & Johnson in January 2022 and was succeeded by Joaquin Duato. He was the seventh person who was the company's chairman and CEO since it became a publicly traded company in 1944. He is a board director of Apple and JP Morgan Chase.
Franz Bernhard Humer is a Swiss-Austrian businessman, and the former chairman of Diageo, and of Roche.
Olivier Brandicourt is a French business executive and physician, and the former chief executive officer of Sanofi.
Stefan Oschmann is a German businessman. He was the CEO of pharma group Merck.
Joey Levin is an American businessman, currently serving as the CEO of IAC. Levin was appointed to the position in June 2015, after previously leading the company's Search & Applications segment. In October 2022, Levin was also appointed as CEO of Angi Inc.
Ramon Martin Chavez is an American investment banker and entrepreneur. He is vice chairman and partner of Sixth Street Partners. Previously, he served in a variety of senior roles at Goldman Sachs, including chief information officer (2014–2017), chief financial officer, and global co-head of the firm's Securities Division. Marty was also a partner and member of Goldman's management committee. He was the chief technology officer and co-founder of Quorum Software Systems and CEO and co-founder of Kiodex. He is chairman of the board of computational pharmaceutical company Recursion, Board Observer of biotech company Earli and longevity biopharma company Cambrian Biopharma, and board member of Alphabet Inc.
Vasant "Vas" Narasimhan is an American physician and the chief executive officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018. He briefly worked at McKinsey before joining Novartis in 2005, where he has held a range of leadership roles, including Global Head of Development for Novartis Vaccines and Global Head of Drug Development & Chief Medical Officer.
Fritz Gerber was a Swiss business executive. He was the Chief Executive Officer of Hoffmann-La Roche from 1978 to 1998. From 1977 to 1991, he was also the CEO of Zurich Insurance Group. Under his management, Roche expanded to become a significant player in biotechnology and diagnostics.
Joaquin Duato is a Spanish-American business executive. He is the chairman and chief executive officer (CEO) of Johnson & Johnson, an American multinational conglomerate. He is the company's eighth CEO since it became a publicly-traded company in 1944. In 2023, Duato received $28.4 million, the highest paid CEO of any major US pharmaceutical company.
Dr. Thomas Schinecker is an Austrian-German pharmaceutical executive and the chief executive officer of the Roche Group since March 2023. He succeeded Severin Schwan, who was elected chairman of the board of directors of the Roche Group.
{{cite web}}
: |last=
has generic name (help)